GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (WBO:DXCM) » Definitions » Investments And Advances

DexCom (WBO:DXCM) Investments And Advances : €37 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is DexCom Investments And Advances?

DexCom's Investments And Advances for the quarter that ended in Mar. 2024 was €37 Mil.

DexCom's quarterly Investments And Advances declined from Sep. 2023 (€36 Mil) to Dec. 2023 (€35 Mil) but then increased from Dec. 2023 (€35 Mil) to Mar. 2024 (€37 Mil).

DexCom's annual Investments And Advances increased from Dec. 2021 (€0 Mil) to Dec. 2022 (€18 Mil) and increased from Dec. 2022 (€18 Mil) to Dec. 2023 (€35 Mil).


DexCom Investments And Advances Historical Data

The historical data trend for DexCom's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom Investments And Advances Chart

DexCom Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 17.94 35.30

DexCom Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 36.08 35.30 36.62

DexCom Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


DexCom (WBO:DXCM) Business Description

Traded in Other Exchanges
Address
6340 Sequence Drive, San Diego, CA, USA, 92121
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.